EPB41 | Erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
SRSF4 | Serine/arginine-rich splicing factor 4 | | | | | | Expressed in all |
MECR | Mitochondrial trans-2-enoyl-CoA reductase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
SNRNP40 | Small nuclear ribonucleoprotein 40kDa (U5) | Predicted membrane proteins
| | | | | Expressed in all |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
TINAGL1 | Tubulointerstitial nephritis antigen-like 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | | | | | | Expressed in all |
KPNA6 | Karyopherin alpha 6 (importin alpha 7) | Plasma proteins
| | | | | Expressed in all |
TXLNA | Taxilin alpha | Cancer-related genes
| | | | | Expressed in all |
EIF3I | Eukaryotic translation initiation factor 3, subunit I | | | | | | Expressed in all |
LCK | Lymphocyte-specific protein tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
HDAC1 | Histone deacetylase 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
MARCKSL1 | MARCKS-like 1 | | | | | | Expressed in all |
BSDC1 | BSD domain containing 1 | | | | | | Expressed in all |
RBBP4 | Retinoblastoma binding protein 4 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
YARS | Tyrosyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
S100PBP | S100P binding protein | | | | | | Expressed in all |
FNDC5 | Fibronectin type III domain containing 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
HPCA | Hippocalcin | Plasma proteins
| | | | | Tissue enriched |
AK2 | Adenylate kinase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
PHC2 | Polyhomeotic homolog 2 (Drosophila) | | | | | | Expressed in all |
HMGB4 | High mobility group box 4 | | | | | | Tissue enriched |
DLGAP3 | Discs, large (Drosophila) homolog-associated protein 3 | | | | | | Group enriched |
TEKT2 | Tektin 2 (testicular) | | | | | | Group enriched |
ADPRHL2 | ADP-ribosylhydrolase like 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
THRAP3 | Thyroid hormone receptor associated protein 3 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
MRPS15 | Mitochondrial ribosomal protein S15 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf109 | Chromosome 1 open reading frame 109 | | | | | | Expressed in all |
CDCA8 | Cell division cycle associated 8 | | | | | | Mixed |
MTF1 | Metal-regulatory transcription factor 1 | Transcription factors
| | | | | Expressed in all |
SF3A3 | Splicing factor 3a, subunit 3, 60kDa | Plasma proteins
| | | | | Expressed in all |
RRAGC | Ras-related GTP binding C | | | | | | Expressed in all |
NDUFS5 | NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) | Mitochondrial proteins
| | | | | Expressed in all |
NT5C1A | 5'-nucleotidase, cytosolic IA | Enzymes
| | | | | Group enriched |
PPIE | Peptidylprolyl isomerase E (cyclophilin E) | Enzymes
| | | | | Expressed in all |
PPT1 | Palmitoyl-protein thioesterase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ZMPSTE24 | Zinc metallopeptidase STE24 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
HIVEP3 | Human immunodeficiency virus type I enhancer binding protein 3 | Transcription factors
| | | | | Mixed |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PPCS | Phosphopantothenoylcysteine synthetase | Enzymes
| | | | | Expressed in all |
PPIH | Peptidylprolyl isomerase H (cyclophilin H) | Enzymes Plasma proteins
| | | | | Expressed in all |
YBX1 | Y box binding protein 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
LEPRE1 | Leucine proline-enriched proteoglycan (leprecan) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
WDR65 | WD repeat domain 65 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
B4GALT2 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
KIF2C | Kinesin family member 2C | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |